Rabeprazole Sodium Delayed-Release
Product manufactured by Sarras Health, Llc
Indications and Purposes
1 Indications And Usage Rabeprazole Sodium Delayed-Release Capsules Are Indicated For Treatment Of Gastroesophageal Reflux Disease (Gerd) In Pediatric Patients 1 To 11 Years Of Age For Up To 12 Weeks. Rabeprazole Sodium Delayed-Release Capsules Are A Proton-Pump Inhibitor (Ppi) Indicated For The Treatment Of Gastroesophageal Reflux Disease (Gerd) In Pediatric Patients 1 To 11 Years Of Age ( 1 ). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Rabeprazole Sodium |
|
ZINC1530935 |